| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1,047.32▲ | 1,041.34▲ | 1,040.03▲ | 1,040.71▲ | 1,039.37▲ |
| MA10 | 1,044.67▲ | 1,036.68▲ | 1,031.18▲ | 1,033.29▲ | 1,052.12▼ |
| MA20 | 1,041.73▲ | 1,027.55▲ | 1,027.62▲ | 1,036.35▲ | 1,010.32▲ |
| MA50 | 1,036.63▲ | 1,032.14▲ | 1,030.53▲ | 1,053.09▼ | 865.60▲ |
| MA100 | 1,030.20▲ | 1,029.24▲ | 1,034.28▲ | 996.05▲ | 852.09▲ |
| MA200 | 1,025.49▲ | 1,034.58▲ | 1,041.66▲ | 874.44▲ | 651.26▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.863▲ | 3.033▲ | 3.445▲ | 1.421▲ | -7.742▼ |
| RSI | 85.980▲ | 73.012▲ | 66.898▲ | 52.392▲ | 59.865▲ |
| STOCH | 87.928▲ | 95.714▲ | 96.295▲ | 50.514 | 38.597 |
| WILL %R | -1.471▲ | -0.578▲ | -0.445▲ | -52.594 | -52.260 |
| CCI | 184.568▲ | 200.199▲ | 159.708▲ | 31.274 | -44.156 |
| ▲ RSI&VOL | $LLY RSI Cross Up and Volume | Set Alert |
| RSI | $LLY RSI(14) Crossed Above 50 | Set Alert |
| ▲ MACD | $LLY MACD(12,26,9) Crossed Above Signal Line | Set Alert |
| MA | $LLY Price Crossed Above MA(26) | Set Alert |
| MA | $LLY Price Crossed Above MA(13) | Set Alert |
| MA | $LLY Price Crossed Above MA(7) | Set Alert |
| CDL | $LLY Engulfing Candlestick Pattern Detected | Set Alert |
| CDL | $LLY Marubozu Candlestick Pattern Detected | Set Alert |
|
Friday, February 27, 2026 04:53 PM
Eli Lilly (NYSE:LLY) reported Phase 3 data showing its oral GLP-1 candidate, orforglipron, produced greater blood sugar and weight reduction in adults with type 2 diabetes than Novo Nordisk’s oral ...
|
|
Friday, February 27, 2026 04:30 AM
US drugmaker Eli Lilly (NYSE: LLY) has launched a new NVIDIA-powered supercomputer, dubbed LillyPod, as part of a broader effort to embed artificial intelligence across its research and manufacturing ...
|
|
Thursday, February 26, 2026 10:43 PM
Eli Lilly and Company (NYSE:LLY) is included among the 14 Best GARP Stocks to Buy According to Analysts. On February 25, RBC Capital initiated coverage of Eli Lilly and Company (NYSE:LLY) with an ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/02/26 | 1,019.17 | 1,053.00 | 1,017.36 | 1,051.99 | 4,324,733 |
| 26/02/26 | 1,024.08 | 1,026.915 | 1,007.3801 | 1,022.02 | 2,664,856 |
| 25/02/26 | 1,036.58 | 1,053.625 | 1,027.00 | 1,028.83 | 2,480,590 |
| 24/02/26 | 1,042.95 | 1,058.90 | 1,024.08 | 1,042.15 | 2,801,866 |
| 23/02/26 | 1,047.02 | 1,064.4499 | 1,034.0001 | 1,058.56 | 4,765,371 |
| 20/02/26 | 1,023.86 | 1,028.65 | 1,002.46 | 1,009.52 | 3,249,409 |
| 19/02/26 | 1,010.82 | 1,025.225 | 1,007.00 | 1,023.22 | 2,145,764 |
| 18/02/26 | 1,032.36 | 1,037.54 | 1,011.31 | 1,020.56 | 3,236,905 |
| 17/02/26 | 1,045.61 | 1,067.00 | 1,034.88 | 1,036.05 | 2,984,593 |
| 13/02/26 | 1,039.98 | 1,064.34 | 1,033.6899 | 1,040.00 | 2,697,700 |
|
|
||||
|
|
||||
|
|